50
Participants
Start Date
January 31, 2010
Primary Completion Date
October 31, 2012
Study Completion Date
October 31, 2012
lisdexamfetamine
oral; 20-70mg/day
Placebo control
20-70mg; oral
Lindner Center of HOPE, Mason
Collaborators (1)
Shire
INDUSTRY
University of Cincinnati
OTHER
Lindner Center of HOPE
OTHER